Clinical Trials in Illinois

Showing 16961-16980 of 19,692 trials

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

NCT01378429

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, safety study of the effects of ciclesonide nasal aerosol (74 mcg) on the HPA axis when administered once daily to male and premenarchal female subjects 6 to 11 years of age with a diagnosis of PAR.

Perennial Allergic RhinitisPAR

Sumitomo Pharma America, Inc.89 participantsStarted Jul 2011

Costa Mesa, California, United States • Stockbridge, Georgia, United States • Normal, Illinois, United States +4 more locations

COMPLETEDPhase 251 miles

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT00425321

The primary objective of the study is to evaluate the safety and tolerability of 100, 200, and 300 mg/day doses of RWJ-445380 for up to 12 weeks in patients with active Rheumatoid Arthritis despite methotrexate therapy.

Rheumatoid Arthritis

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.259 participantsStarted Dec 2006

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +39 more locations

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Find Trials by Condition in Illinois

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

Tiotropium / Respimat One-Year Study

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Study of Epratuzumab in Systemic Lupus Erythematosus

National Lung Screening Trial (NLST) Screening

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Global® AP™ Total Shoulder Arthroplasty

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome

VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept